1-9 of 9
David S. Ettinger
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 6551: Comprehensive genomic and transcriptomic analyses capture the effects of epigenetic therapy priming on immune checkpoint blockade response in non-small cell lung cancer

Free
Blair V. Landon, Kristen A. Marrone, Michael J. Topper, Akshaya Annapragada, Hua-Ling Tsai, Archana Balan, Noushin Niknafs, Christopher Cherry, James R. White, Gavin Pereira, Vilmos Adleff, Chen Hu, Joanne Riemer, Margaret Fitzpatrick, Patrick Forde, Christine L. Hann, Ronan J. Kelly, David S. Ettinger, Benjamin Levy, Jorge Nieva, James Herman, Victor E. Velculescu, Stephen Baylin, Julie Brahmer, Valsamo Anagnostou
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 6551.
https://doi.org/10.1158/1538-7445.AM2024-6551
Published: 22 March 2024
View articletitled, Abstract 6551: Comprehensive genomic and transcriptomic analyses capture the effects of epigenetic therapy priming on immune checkpoint blockade response in non-small cell lung cancer
Journal Articles

Phase I and Pharmacological Study of the Novel Topoisomerase I Inhibitor 7-Ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) Administered as a Ninety-Minute Infusion Every 3 Weeks

Available to Purchase
Eric K. Rowinsky, Louise B. Grochow, David S. Ettinger, Susan E. Sartorius, Barbara G. Lubejko, Tian-Ling Chen, Michael K. Rock, Ross C. Donehower
Journal: Cancer Research
Cancer Res (1994) 54 (2): 427–436.
Published: 01 January 1994
View articletitled, Phase I and Pharmacological Study of the Novel Topoisomerase I Inhibitor 7-Ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) Administered as a Ninety-Minute Infusion Every 3 Weeks
Open the PDF for Phase I and Pharmacological Study of the Novel Topoisomerase I Inhibitor 7-Ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) Administered as a Ninety-Minute Infusion Every 3 Weeks in another window
Journal Articles

Phase I and Pharmacological Study of the Pulmonary Cytotoxin 4-Ipomeanol on a Single Dose Schedule in Lung Cancer Patients: Hepatotoxicity Is Dose Limiting in Humans

Available to Purchase
Eric K. Rowinsky, Dennis A. Noe, David S. Ettinger, Michaele C. Christian, Barbara G. Lubejko, Elliot K. Fishman, Susan E. Sartorius, Michael R. Boyd, Ross C. Donehower
Journal: Cancer Research
Cancer Res (1993) 53 (8): 1794–1801.
Published: 01 April 1993
View articletitled, Phase I and Pharmacological Study of the Pulmonary Cytotoxin 4-Ipomeanol on a Single Dose Schedule in Lung Cancer Patients: Hepatotoxicity Is Dose Limiting in Humans
Open the PDF for Phase I and Pharmacological Study of the Pulmonary Cytotoxin 4-Ipomeanol on a Single Dose Schedule in Lung Cancer Patients: Hepatotoxicity Is Dose Limiting in Humans in another window
Journal Articles

Phase I and Pharmacokinetic Study of Hepsulfam (NSC 329680)

Available to Purchase
Carolyn B. Hendricks, Louise B. Grochow, Eric K. Rowinsky, Arlene A. Forastiere, William P. McGuire, David S. Ettinger, Susan Sartorius, Barbara Lubejko, Ross C. Donehower
Journal: Cancer Research
Cancer Res (1991) 51 (21): 5781–5785.
Published: 01 November 1991
View articletitled, Phase I and Pharmacokinetic Study of Hepsulfam (NSC 329680)
Open the PDF for Phase I and Pharmacokinetic Study of Hepsulfam (NSC 329680) in another window
Journal Articles

Phase I and Pharmacokinetic Study of Brequinar Sodium (NSC 368390)

Available to Purchase
Dennis A. Noe, Eric K. Rowinsky, Huey-Shin L. Shen, Barbara V. Clarke, Louise B. Grochow, William B. McGuire, Alexander Hantel, David B. Adams, Martin D. Abeloff, David S. Ettinger, Ross C. Donehower
Journal: Cancer Research
Cancer Res (1990) 50 (15): 4595–4599.
Published: 01 August 1990
View articletitled, Phase I and Pharmacokinetic Study of Brequinar Sodium (NSC 368390)
Open the PDF for Phase I and Pharmacokinetic Study of Brequinar Sodium (NSC 368390) in another window
Journal Articles

Phase I Study and Pharmacodynamics of Piroxantrone (NSC 349174), a New Anthrapyrazole

Available to Purchase
Alexander Hantel, Ross C. Donehower, Eric K. Rowinsky, Estil Vance, Barbara V. Clarke, William P. McGuire, David S. Ettinger, Dennis A. Noe, Louise B. Grochow
Journal: Cancer Research
Cancer Res (1990) 50 (11): 3284–3288.
Published: 01 June 1990
View articletitled, Phase I Study and Pharmacodynamics of Piroxantrone (NSC 349174), a New Anthrapyrazole
Open the PDF for Phase I Study and Pharmacodynamics of Piroxantrone (NSC 349174), a New Anthrapyrazole in another window
Journal Articles

Phase I and Pharmacodynamic Study of Taxol in Refractory Acute Leukemias

Available to Purchase
Eric K. Rowinsky, Philip J. Burke, Judith E. Karp, Robert W. Tucker, David S. Ettinger, Ross C. Donehower
Journal: Cancer Research
Cancer Res (1989) 49 (16): 4640–4647.
Published: 01 August 1989
View articletitled, Phase I and Pharmacodynamic Study of Taxol in Refractory Acute Leukemias
Open the PDF for Phase I and Pharmacodynamic Study of Taxol in Refractory Acute Leukemias in another window
Journal Articles

Prolonged Infusion of Hexamethylene Bisacetamide: A Phase I and Pharmacological Study

Available to Purchase
Eric K. Rowinsky, David S. Ettinger, William P. McGuire, Dennis A. Noe, Louise B. Grochow, Ross C. Donehower
Journal: Cancer Research
Cancer Res (1987) 47 (21): 5788–5795.
Published: 01 November 1987
View articletitled, Prolonged Infusion of Hexamethylene Bisacetamide: A Phase I and Pharmacological Study
Open the PDF for Prolonged Infusion of Hexamethylene Bisacetamide: A Phase I and Pharmacological Study in another window
Journal Articles

Carcinoembryonic Antigen for Monitoring Patients with Small Cell Carcinoma of the Lung during Treatment

Available to Purchase
T. Phillip Waalkes, Martin D. Abeloff, Kwang B. Woo, David S. Ettinger, Raymond W. Ruddon, Paul Aldenderfer
Journal: Cancer Research
Cancer Res (1980) 40 (12): 4420–4427.
Published: 01 December 1980
View articletitled, Carcinoembryonic Antigen for Monitoring Patients with Small Cell Carcinoma of the Lung during Treatment
Open the PDF for Carcinoembryonic Antigen for Monitoring Patients with Small Cell Carcinoma of the Lung during Treatment in another window